News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) Hunts For Suitors To Buy Older Drugs, Eyes Cash To Focus On Most Lucrative Areas Of Business


5/30/2014 7:33:26 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlaxoSmithKline (GSK.L) has invited private equity firms to consider making offers for a range of its older drugs sold in Western markets, according to three people with direct knowledge of the matter. The move is part of a reshaping of the drugmaker's business, which also involves a major asset swap deal struck last month with Novartis (NOVN.VX). Chief Executive Andrew Witty said last month that Britain's biggest pharmaceuticals company could dispose of individual medicines or a broader portfolio of older established products.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Telegraph
Read at News Release
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES